Gene fusions involving the FET gene family (FUS, EWSR1, and TAF15) act as drivers of numerous cancer entities. The resulting chimeric proteins are widely viewed as aberrant transcriptional regulators that promote malignant transformation through chromatin and enhancer reprogramming. Here, we show that FET fusion oncopr...
Loïc Ongena, Eva Lucarelli, Laurence Dubois et al.· bioRxiv· 0 citations
Genomic and DNA methylation-based analyses have transformed the classification of central nervous system (CNS) tumors by enabling robust molecular diagnosis and subclassification. However, these approaches primarily define tumor identity and do not directly capture the functional state of intracellular signaling networ...
Dennis Friedel, Rhaissa Ribeiro da Silva, Ivan Abdulrazak Ahmed et al.· Acta Neuropathologica· 0 citations
Functional experiments demonstrate that LMO7 silencing decreases clonogenicity and migratory capacity in vitro and suppresses primary tumor growth and metastatic dissemination in vivo, and illustrate how integrating functional, spatial and clinical data can uncover oncogene-driven effectors of metastasis.
Veronika Buršić, Heng Luo, C. Hénon et al.· bioRxiv· 0 citations
Metastatic dissemination represents the major determinant of poor clinical outcome across cancer entities. Yet, how driver oncogenes shape transcriptional programs facilitating metastasis is poorly understood. In Ewing sarcoma (EwS) – a highly aggressive pediatric bone and soft-tissue sarcoma driven by chimeric FET::ET...
Veronika Buršić, Heng Luo, C. Hénon et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.